Interaction between LL-37 and CsrRS of group A Streptococcus
LL-37 与 A 族链球菌 CsrRS 之间的相互作用
基本信息
- 批准号:8109214
- 负责人:
- 金额:$ 5.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAntibiotic TherapyAreaBenignBindingCellular biologyClinicalDiseaseExotoxinsFlesh-Eating BacteriaGene Expression ProfileGeneticGenetic TranscriptionHumanHyaluronic AcidImmuneImmune responseImmune systemInfectionInvadedLifeLightMembraneMicrobeNecrotizing fasciitisOrganismOropharyngealPathogenesisPeptidesPharyngeal structurePharyngitisPhenotypePhosphotransferasesPlaguePlayProcessPublic HealthReactionRegulonRheumatic Heart DiseaseRoleSignal TransductionSiteStagingStreptococcus pyogenesStreptolysinsSystemToxic Shock SyndromeToxinVirulenceVirulence FactorsVirulentWorkantimicrobial peptide LL-37capsulecathelicidincell typefascinateimprovedinsightkeratinocytekillingsmacrophagemultiple myeloma M Proteinpathogenpublic health relevanceresponsesensor
项目摘要
DESCRIPTION (provided by applicant): Group A Streptococcus (GAS, also known as Streptococcus pyogenes) is a common human pathogen, most frequently causing pharyngitis or "strep throat." However, severe invasive infections like necrotizing fasciitis and toxic shock syndrome are also caused by this organism, leading to its nickname in the lay press - "flesh-eating bacteria." This work will help explain the process by which a microbe in the throat can invade and cause life-threatening illness. Previous studies found that GAS alter transcription of multiple virulence factors in response to the human cathelicidin, LL-37, an antimicrobial peptide. A membrane-bound sensor kinase (CsrS) and its cytoplasmic response regulator (CsrR) appear to drive this reaction. This application aims to examine the role of LL-37 in stimulating an invasive phenotype in GAS. We will focus on the interaction of GAS with two host cell types commonly encountered early in infection: keratinocytes and macrophages. We will examine the role that LL-37 and CsrRS play in GAS's ability to avoid internalization and killing. Overall, these studies will examine a fascinating evolutionary interaction between a human pathogen and the innate immune system, offering new insights into the pathogenesis of GAS infections.
PUBLIC HEALTH RELEVANCE: The public health burden of GAS infection remains high. Sequelae of infection, including rheumatic heart disease, continue to plague especially developing areas, where prompt antibiotic therapy is unavailable. Additionally, there has been a rise in invasive GAS infections as a new, more virulent strain has spread around the globe. For these reasons, improving our understanding of the earliest stages of human infection will be essential to battling this common yet evolving pathogen.
描述(由申请人提供):A组链球菌(GAS,也称为化脓性链球菌)是一种常见的人类病原体,最常引起咽炎或“链球菌性咽喉炎”。然而,严重的侵入性感染,如坏死性筋膜炎和中毒性休克综合征也是由这种微生物引起的,这导致了它在新闻界的绰号-“食肉细菌“。“这项工作将有助于解释喉咙中的微生物入侵并导致危及生命的疾病的过程。以前的研究发现,GAS改变多种毒力因子的转录,以响应人类cathelicidin,LL-37,一种抗菌肽。膜结合传感器激酶(CsrS)和其细胞质反应调节因子(CsrR)似乎驱动这种反应。本申请旨在检查LL-37在刺激GAS中的侵袭性表型中的作用。我们将重点关注GAS与感染早期常见的两种宿主细胞类型的相互作用:角质形成细胞和巨噬细胞。我们将研究LL-37和CsrRS在GAS避免内化和杀伤的能力中所起的作用。总的来说,这些研究将研究人类病原体和先天免疫系统之间迷人的进化相互作用,为GAS感染的发病机制提供新的见解。
公共卫生相关性:GAS感染的公共卫生负担仍然很高。感染的后遗症,包括风湿性心脏病,继续困扰着特别是发展中地区,那里没有及时的抗生素治疗。此外,随着一种新的、毒性更强的菌株在地球仪各地传播,侵袭性GAS感染也有所增加。出于这些原因,提高我们对人类感染最早阶段的理解对于对抗这种常见但不断发展的病原体至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Frank Love其他文献
John Frank Love的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Frank Love', 18)}}的其他基金
Interaction between LL-37 and CsrRS of group A Streptococcus
LL-37 与 A 族链球菌 CsrRS 之间的相互作用
- 批准号:
8004306 - 财政年份:2010
- 资助金额:
$ 5.87万 - 项目类别:
相似海外基金
SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
- 批准号:
2213034 - 财政年份:2023
- 资助金额:
$ 5.87万 - 项目类别:
Cooperative Agreement
Personalized Antibiotic Therapy in the Emergency Department: PANTHER Trial
急诊科的个性化抗生素治疗:PANTHER 试验
- 批准号:
10645528 - 财政年份:2023
- 资助金额:
$ 5.87万 - 项目类别:
Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections
提高慢性感染联合抗生素治疗疗效的策略
- 批准号:
10736285 - 财政年份:2023
- 资助金额:
$ 5.87万 - 项目类别:
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
- 批准号:
10603486 - 财政年份:2023
- 资助金额:
$ 5.87万 - 项目类别:
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
- 批准号:
449379 - 财政年份:2020
- 资助金额:
$ 5.87万 - 项目类别:
Studentship Programs
Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia
患有晚期痴呆症的疗养院居民的临终干预和抗生素治疗的性别差异
- 批准号:
422034 - 财政年份:2020
- 资助金额:
$ 5.87万 - 项目类别:
Optimizing outpatient parenteral antibiotic therapy to support hospital-in-the-home program across the unique environmental conditions of Australia
优化门诊肠外抗生素治疗,以支持澳大利亚独特环境条件下的家庭医院计划
- 批准号:
nhmrc : 1197866 - 财政年份:2020
- 资助金额:
$ 5.87万 - 项目类别:
Investigator Grants
Resistance evolution in the presence of combination antibiotic therapy
联合抗生素治疗下耐药性的演变
- 批准号:
2241853 - 财政年份:2019
- 资助金额:
$ 5.87万 - 项目类别:
Studentship
Host-pathogen interactions in antibiotic therapy for listeriosis
李斯特菌病抗生素治疗中宿主与病原体的相互作用
- 批准号:
18K07106 - 财政年份:2018
- 资助金额:
$ 5.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones
多用途靶向纳米抗生素疗法可对抗骨骼中的严重感染
- 批准号:
9788269 - 财政年份:2018
- 资助金额:
$ 5.87万 - 项目类别: